An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ

Alexander S Banks1, Fiona E McAllister2, João Paulo G Camporez3

  • 1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature
|November 20, 2014
PubMed

Insights

Cyclin-dependent kinase 5 (Cdk5) normally suppresses extracellular signal-regulated kinases (ERK) to prevent insulin resistance. Inhibiting MEK/ERK improves insulin sensitivity, offering a potential treatment for type 2 diabetes.

Area of Science:

  • Metabolic disease research
  • Molecular endocrinology
  • Diabetes pathogenesis

Background:

  • Obesity-induced insulin resistance is a precursor to type 2 diabetes.
  • Phosphorylation of peroxisome proliferator-activated receptor γ (PPARγ) at serine 273 by Cdk5 stimulates diabetogenic gene expression.
  • Current anti-diabetic drugs targeting PPARγ inhibit this phosphorylation.

Purpose of the Study:

  • To investigate the role of Cdk5 in adipose tissue on PPARγ phosphorylation and insulin resistance.
  • To identify the kinases responsible for PPARγ serine 273 phosphorylation in the absence of Cdk5.
  • To explore the therapeutic potential of targeting the identified kinase pathway for type 2 diabetes treatment.

Main Methods:

  • Generation of mice with adipose-specific Cdk5 ablation.
  • Proteomic analysis to identify activated kinases in knockout mice.
  • In vivo and in vitro experiments to confirm direct phosphorylation of PPARγ by ERK.
  • Pharmacological inhibition of MEK and ERK in obese mouse models.

Main Results:

  • Adipose-specific Cdk5 ablation paradoxically increased PPARγ serine 273 phosphorylation and worsened insulin resistance.
  • Extracellular signal-regulated kinases (ERK) were identified as activated kinases in Cdk5-ablated mice.
  • ERK directly phosphorylates PPARγ at serine 273, while Cdk5 suppresses ERK activity via MEK.
  • Pharmacological inhibition of MEK/ERK significantly improved insulin resistance in obese mice and rescued Cdk5 ablation effects.

Conclusions:

  • An ERK/Cdk5 signaling axis critically regulates PPARγ function in adipose tissue.
  • ERK-mediated phosphorylation of PPARγ contributes to insulin resistance.
  • Inhibitors of MEK/ERK signaling represent a promising therapeutic strategy for type 2 diabetes.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K